Editas Medicine (EDIT) PT Lowered to $60 at Raymond James
Tweet
Share
E-mailGet Alerts EDIT Hot Sheet
Price: $2.81 -1.06%
Rating Summary:
11 Buy, 13 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
11 Buy, 13 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Raymond James analyst Steven Seedhouse lowered the price target on Editas Medicine (NASDAQ: EDIT) to $60.00 (from $65.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Godrej Consumer Products Ltd. (GCPL:IN) PT Lowered to INR1,150 at Macquarie
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$440 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
